Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
January 9, 2018 - The FDA approved a new warning to the Jevtana (cabazitaxel) drug label regarding the risk of urinary disorders including cystitis.
Download PDF
Return to publications
